← Back to catalogue

FLEX Mono Rb A-Hu Postmeiotic Segregation Increased 2 Cl EP51 RTU (Link)

FDA UDI

Class I (US FDA UDI)

by Agilent Technologies Inc.

Identity

Trade Name
FLEX Mono Rb A-Hu Postmeiotic Segregation Increased 2 Cl EP51 RTU (Link) FDA UDI
Generic Name
Postmeiotic segregation increased 2 (PMS2) IVD, antibody FDA UDI
Device Name
FLEX Monoclonal Rabbit Anti-Human Postmeiotic Segregation Increased 2 Clone EP51 Ready-to-Use (Link) FDA UDI
Model / Reference
IR087 FDA UDI
Description
FLEX Monoclonal Rabbit Anti-Human Postmeiotic Segregation Increased 2 Clone EP51 Ready-to-Use (Link) FDA UDI

Identifiers

Primary DI / UDI-DI
05700571106495 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Postmeiotic segregation increased 2 (PMS2) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Postmeiotic segregation increased 2 (PMS2) IVD, antibody

FLEX Mono Rb A-Hu Postmeiotic Segregation Increased 2 Cl EP51 RTU (Link) by Agilent Technologies Inc. — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Postmeiotic segregation increased 2 (PMS2) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Agilent Technologies Inc.

Sources (1)

  • FDA UDI eeb85361-bcc0-492e-950c-18e5703df118 36 fields · synced May 30, 2026